Free Trial

Monte Rosa Therapeutics (GLUE) News Today

Monte Rosa Therapeutics logo
$5.26 -0.03 (-0.57%)
Closing price 04:00 PM Eastern
Extended Trading
$5.25 -0.01 (-0.19%)
As of 04:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GLUE Latest News

Analysts Set Expectations for GLUE Q4 Earnings
Monte Rosa Therapeutics Insider Ups Holding During Year
Monte Rosa Therapeutics: Exercise Extreme Caution
FY2029 Earnings Estimate for GLUE Issued By Wedbush
Monte Rosa Therapeutics price target raised to $17 from $15 at Wedbush
Wedbush Sticks to Its Buy Rating for Monte Rosa Therapeutics (GLUE)
Monte Rosa Therapeutics reports Q4 revenue $60.6M, consensus $51.9M
Monte Rosa Therapeutics files $400M mixed securities shelf
Brokers Offer Predictions for GLUE FY2024 Earnings
Monte Rosa Therapeutics initiated with an Outperform at LifeSci Capital
Get Monte Rosa Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GLUE and its competitors with MarketBeat's FREE daily newsletter.

GLUE Media Mentions By Week

GLUE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GLUE
News Sentiment

-0.46

0.56

Average
Medical
News Sentiment

GLUE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GLUE Articles
This Week

0

2

GLUE Articles
Average Week

Get Monte Rosa Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GLUE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GLUE) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners